In addition to Keap1 and Nrf2, somatic mutations leading to Nrf2 accumulation in cancers have also been discovered in other key components of the Keap1–Nrf2 pathway, such as Cul3 and Rbx1 (39–41). This evidence concerns the gene CUL3 and cancer.